Chains & Business

CVS Generic Drugs Suit Fails to Get Class ActionCalifornia judge blocks 11 classes in suit that claims CVS charged insurers and insured patients more than uninsured patients.
Rite Aid, Albertsons Expand Naloxone AccessRite Aid and Albertsons expand naloxone Access, hoping to curb the opioid epidemic.
Walgreens faces anti-tobacco effort ahead of annual meetingTwo organizations opposed to tobacco sales at pharmacy chains are turning their attention to Walgreens’ annual shareholder meeting on January 26.
Report: Pharmacists dispensing dangerous drug combosWalgreens, CVS Health and other drug chains promised to improve procedures after a Chicago Tribune investigation found that pharmacists at several retail chains filled prescriptions with dangerous drug combinations.
Pharmacies Play a Key Role in One Business’ Mission to Help the Uninsured
Analyst: CVS’ OptumRx deal amps up competitionLast month, OptumRx and CVS Pharmacy announced that they are partnering to provide more convenient choices and lower costs for patients.
Omnicare to pay $28 million for kickback schemeOmnicare agreed to settle claims that it conspired with Abbott Laboratories “to engage in a number of disguised kickback arrangements to increase overall use of Depakote,”
Walgreens expands 90-day pharmacy program offeringThe retail chain has linked itself with EnvisionRx.
The Evolution of Group Purchasing OrganizationsSomewhere in the United States, there may be a retail or specialty pharmacy that is not part of a group purchasing organization (GPO). If there is such a pharmacy, it is very hard to find.
Battling DIR FeesThe profitability of both chain and independent pharmacies is being affected by direct and indirect remuneration fees that insurers are retroactively charging pharmacies after filling Medicare Part D prescriptions.